Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) Director Larry Jobe purchased 2,803 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The stock was acquired at an average price of $4.12 per share, for a total transaction of $11,548.36. Following the completion of the purchase, the director directly owned 70,000 shares of the company’s stock, valued at $288,400. This represents a 4.17% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link.
Mannatech Trading Up 11.9%
MTEX stock opened at $4.42 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.59 and a current ratio of 1.09. The company’s 50-day simple moving average is $5.52 and its 200 day simple moving average is $7.24. Mannatech, Incorporated has a 52 week low of $3.80 and a 52 week high of $12.45. The company has a market capitalization of $8.53 million, a PE ratio of -0.66 and a beta of 0.61.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.49 EPS for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The business had revenue of $24.92 million for the quarter.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
- Five stocks we like better than Mannatech
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
